Genomic & Biopharma News

Mass exodus of Amgen sales reps sparks legal battle with multiple myeloma rival Karyopharm
After 19 salespeople resigned from Amgen last year to join Karyopharm, which is preparing to launch a rival multiple myeloma drug, Amgen sued, alleging theft of trade secrets. Now, as it awaits an FDA decision on its multiple myeloma drug selinexor, Karyopharm is fighting to get the suit thrown out.
Fierce Pharma, 2019-05-24 14:06:55

Novocure nets approval for its Tumor Treating Fields therapy in mesothelioma
Novocure’s tumor-treating electric field system scored a first-line FDA approval in mesothelioma, making it the first new treatment option in the indication in more than 15 years.
Fierce Biotech, 2019-05-24 14:05:40

FLX Bio keeps it capital in RAPT Therapeutics rebrand
FLX Bio is renaming itself RAPT Therapeutics to reflect its expansion into allergy and inflammatory diseases.
Fierce Biotech, 2019-05-24 13:59:07

Trump to unveil executive order to force drug cost disclosure: WSJ
Think disclosing drug list prices in TV ads is all the transparency the Trump administration is asking for? Think again. The president is reportedly going to sign an executive order that would require disclosure of prices across the healthcare industry, including drug prices.
Fierce Pharma, 2019-05-24 13:51:19

Cell scientist receives $1.9 million NIH grant to study muscle regeneration
As people age, their muscle regeneration capacity declines in part because they can no longer make enough muscle stem cells to replace damaged tissue.
News Medical Life Sciences, 2019-05-24 13:48:44

Research sheds new light on the function of frequently mutated cancer protein
New research from The Wistar Institute sheds light on the function of the ARID1A protein, encoded by a gene that is among the most frequently mutated across human cancers.
News Medical Life Sciences, 2019-05-24 13:44:04

Use of buprenorphine to treat opioid addiction proliferates in California
Buprenorphine, a relative newcomer in the treatment of opioid addiction, is growing in popularity among California doctors as regulatory changes, physician training and other initiatives make the medication more widely accessible.
News Medical Life Sciences, 2019-05-24 13:34:47

Pelican Newspaper: Gene profiling at Ocean Ridge Biosciences to unlock mysteries of the human body
Identifying the markers for pancreatic cancer may have happened here in a 5,400 square foot facility where scientists routinely practice next generation RNA profiling and biomarker discovery. Please read the PDF for more details
ORB Company News, 2016-11-25 18:55:37

Pelican Newspaper: Gene profiling at Ocean Ridge Biosciences to unlock mysteries of the human body
Identifying the markers for pancreatic cancer may have happened here in a 5,400 square foot facility where scientists routinely practice next generation RNA profiling and biomarker discovery. Please read the PDF for more details
ORB Company News, 2016-11-25 18:55:37

ISPOR examines how real-world evidence can be improved with patient-provided information
ISPOR, the professional society for health economics and outcomes research, examined how real-world evidence can be improved with patient-provided information this afternoon at its ISPOR 2019 annual conference with the session, "Leveraging Patient-Provided Information to Improve Real-World Evidence: Getting to Good Practices on How."
News Medical Life Sciences, 2019-05-24 13:28:50

New UCI-led study shows crowdsourced traffic data could reduce mortality
A new UCI-led pilot study finds, on average, Waze "crash alerts" occur two minutes and 41 seconds prior to their corresponding California Highway Patrol (CHP)-reported crash.
News Medical Life Sciences, 2019-05-24 13:25:38